Genomic Valley Biotech has confirmed that the company do not fall under the ambit of 'Large Entities' as per the SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 regarding the Fund raising of Debt Securities by Large Entities and do not have an outstanding long-term borrowing of Rs 100 crores or above with original maturity of more than one year.
The above information is a part of company’s filings submitted to BSE.